Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2604 (LINC02604)

Target
LINC02604
Molecular classification
Other (long non-coding RNA)
01

Overview

Long intergenic non-protein coding RNA 2604 (LINC02604), also known as lncHERG, is a long non-coding RNA associated with various cancers, most notably glioblastoma and colorectal cancer. It has been found to be highly expressed in these malignancies and acts as a competitive endogenous RNA (ceRNA), likely through sponging tumor suppressor microRNAs such as miR-940 and others, leading to the derepression of oncogenic mRNA targets. LINC02604 is involved in the regulation of cell proliferation, apoptosis, and metastasis. Increased expression correlates with poor prognosis, aggressive disease features, and higher patient mortality. Its strong diagnostic utility has been demonstrated for colorectal cancer, with very high sensitivities and specificities in published biomarker studies. In glioblastoma, it is being studied as both a diagnostic and prognostic biomarker, though direct drug interactions are currently unknown[1][4].

Other names
lncHERGhighly expressed long noncoding RNA in glioblastoma
02

Biological functions

Cell proliferationApoptosisMetastasisCompeting endogenous RNA (ceRNA) activity (e.g., sponging miRNAs)
03

Disease associations

CancerGlioblastomaColorectal cancer
04

Biomarkers

Diagnostic biomarker for colorectal cancer[1]Prognostic biomarker for glioblastoma[4]

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2604 (LINC02604).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2604 (LINC02604).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call